administrat0r

Roche’s lung cancer combo treatment wins FDA approval

Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.

J&J unit to pay $360 million to U.S. to resolve charity kickback probe

A Johnson & Johnson unit will pay the U.S. government $360 million to resolve an investigation into its financial support of a charity that helped Medicare patients cover out-of-pocket drug costs, the Justice Department said on Thursday.

U.S. healthcare spending growth slows for second year in a row

Healthcare spending growth in the United States slowed for the second year in a row in 2017, mainly due to slower spending growth for hospital care, physician and clinical services as well as retail prescription drugs, according to a report from the U.S. Centers for Medicare and Medicaid Services.

More evidence fruits and greens can be good for the brain

(Reuters Health) – – Middle-aged men who eat lots of fruits and vegetables may be lowering their odds of cognitive problems as they get on in years, compared to peers who don’t consume these foods very often, a U.S. study suggests.

Mallinckrodt plans to spin off specialty generics business

Mallinckrodt Plc said on Thursday it planned to spin off its specialty generics business to shareholders by the second half of 2019, capping a two-year long effort to look for strategic options for the unit.

Arrest of Huawei ‘heiress’ throws rare spotlight on family

Like many top Chinese executives, Meng Wanzhou is a mysterious figure even in her home country, but the 46-year-old chief financial officer of Huawei Technologies had been widely tipped to one day take the helm of the tech giant her father founded.